|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits with other banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities available for sale at estimated fair value (amortized cost-$3,531,722 at June 30, 2026 and $3,264,860 at December 31, 2025, allowance for credit losses of $0 at June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Securities held to maturity, net of allowance for credit losses of $14 at June 30, 2026 and $16 at December 31, 2025 (estimated fair value-$1,020 at June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Equity securities at estimated fair value | ||||||||||||||||||||
| Other investment securities | ||||||||||||||||||||
| Loans held for sale measured using fair value option | ||||||||||||||||||||
| Loans and leases | ||||||||||||||||||||
| Less: Unearned income | ||||||||||||||||||||
| Loans and leases, net of unearned income | ||||||||||||||||||||
| Less: Allowance for loan and lease losses | ||||||||||||||||||||
| Net loans and leases | ||||||||||||||||||||
| Bank premises and equipment | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Mortgage servicing rights | ||||||||||||||||||||
| Bank-owned life insurance ("BOLI") | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings: | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Federal Home Loan Bank ("FHLB") borrowings | ||||||||||||||||||||
| Other long-term borrowings | ||||||||||||||||||||
| Reserve for lending-related commitments | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Preferred stock, $1.00 par value; Authorized-50,000,000 shares, none issued | ||||||||||||||||||||
| Common stock, $2.50 par value; Authorized-200,000,000 shares; issued-151,183,683 and 150,856,999 at June 30, 2026 and December 31, 2025, respectively, including 14,241,534 and 10,976,752 shares in treasury at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
